Functional studies of chronic lymphocytic leukemia B cells expressing β2-integrin type complement receptors CR3 and CR4

Barbara Uzonyi, Bernadett Mácsik-Valent, Szilvia Lukácsi, Richárd Kiss, Katalin Török, Mariann Kremlitzka, Z. Bajtay, J. Demeter, Csaba Bödör, A. Erdei

Research output: Article

2 Citations (Scopus)

Abstract

The expression and role of CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in B cells are not yet explored in contrast to myeloid cells, where these β2-integrin type receptors are known to participate in various cellular functions, including phagocytosis, adherence and migration. Here we aimed to reveal the expression and role of CR3 and CR4 in human B cells. In B cells of healthy donors CR3 and CR4 are scarcely expressed. However, two patients with chronic lymphocytic leukemia (CLL) characterized by a peculiar immune-phenotype containing both CD5-positive and CD5-negative B cell populations made possible to study these molecules in distinct B cell subsets. We found that CD11b and CD11c were expressed on both CD5-positive and CD5-negative B cells, albeit to different extents. Our data suggest that these receptors are involved in spreading, since this activity of CpG-activated B cells on fibrinogen could be partially blocked by monoclonal antibodies specific for CD11b or CD11c. CpG-stimulation lead to proliferation of both CD5-positive and CD5-negative B cells of the patients with a less pronounced effect on the CD5-positive cells. In contrast to normal B cells, CLL B cells of both patients reacted to CpG-stimulation with robust IL-10 production. The concomitant, suboptimal stimulus via the BCR and TLR9 exerted either a synergistic enhancing effect or resulted in inhibition of proliferation and IL-10 production of patients’ B cells. Our data obtained studying B cells of leukemic patients point to the role of CR3 and probably CR4 in the interaction of tumor cells with the microenvironment and suggest the involvement of IL-10 producing B cells in the pathologic process.

Original languageEnglish
Pages (from-to)73-81
Number of pages9
JournalImmunology Letters
Volume189
DOIs
Publication statusPublished - szept. 1 2017

Fingerprint

Complement 3d Receptors
B-Cell Chronic Lymphocytic Leukemia
Integrins
B-Lymphocytes
Interleukin-10
B-Lymphocyte Subsets
Cellular Microenvironment
Myeloid Cells
Pathologic Processes
Phagocytosis
Fibrinogen

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Functional studies of chronic lymphocytic leukemia B cells expressing β2-integrin type complement receptors CR3 and CR4. / Uzonyi, Barbara; Mácsik-Valent, Bernadett; Lukácsi, Szilvia; Kiss, Richárd; Török, Katalin; Kremlitzka, Mariann; Bajtay, Z.; Demeter, J.; Bödör, Csaba; Erdei, A.

In: Immunology Letters, Vol. 189, 01.09.2017, p. 73-81.

Research output: Article

Uzonyi, Barbara ; Mácsik-Valent, Bernadett ; Lukácsi, Szilvia ; Kiss, Richárd ; Török, Katalin ; Kremlitzka, Mariann ; Bajtay, Z. ; Demeter, J. ; Bödör, Csaba ; Erdei, A. / Functional studies of chronic lymphocytic leukemia B cells expressing β2-integrin type complement receptors CR3 and CR4. In: Immunology Letters. 2017 ; Vol. 189. pp. 73-81.
@article{0591ef4878094e80ba2db00334f2ae63,
title = "Functional studies of chronic lymphocytic leukemia B cells expressing β2-integrin type complement receptors CR3 and CR4",
abstract = "The expression and role of CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in B cells are not yet explored in contrast to myeloid cells, where these β2-integrin type receptors are known to participate in various cellular functions, including phagocytosis, adherence and migration. Here we aimed to reveal the expression and role of CR3 and CR4 in human B cells. In B cells of healthy donors CR3 and CR4 are scarcely expressed. However, two patients with chronic lymphocytic leukemia (CLL) characterized by a peculiar immune-phenotype containing both CD5-positive and CD5-negative B cell populations made possible to study these molecules in distinct B cell subsets. We found that CD11b and CD11c were expressed on both CD5-positive and CD5-negative B cells, albeit to different extents. Our data suggest that these receptors are involved in spreading, since this activity of CpG-activated B cells on fibrinogen could be partially blocked by monoclonal antibodies specific for CD11b or CD11c. CpG-stimulation lead to proliferation of both CD5-positive and CD5-negative B cells of the patients with a less pronounced effect on the CD5-positive cells. In contrast to normal B cells, CLL B cells of both patients reacted to CpG-stimulation with robust IL-10 production. The concomitant, suboptimal stimulus via the BCR and TLR9 exerted either a synergistic enhancing effect or resulted in inhibition of proliferation and IL-10 production of patients’ B cells. Our data obtained studying B cells of leukemic patients point to the role of CR3 and probably CR4 in the interaction of tumor cells with the microenvironment and suggest the involvement of IL-10 producing B cells in the pathologic process.",
keywords = "Adhesion and spreading, CLL B cells, Expression of CR3 and CR4, IL-10 production",
author = "Barbara Uzonyi and Bernadett M{\'a}csik-Valent and Szilvia Luk{\'a}csi and Rich{\'a}rd Kiss and Katalin T{\"o}r{\"o}k and Mariann Kremlitzka and Z. Bajtay and J. Demeter and Csaba B{\"o}d{\"o}r and A. Erdei",
year = "2017",
month = "9",
day = "1",
doi = "10.1016/j.imlet.2017.05.016",
language = "English",
volume = "189",
pages = "73--81",
journal = "Immunology Letters",
issn = "0165-2478",
publisher = "Elsevier",

}

TY - JOUR

T1 - Functional studies of chronic lymphocytic leukemia B cells expressing β2-integrin type complement receptors CR3 and CR4

AU - Uzonyi, Barbara

AU - Mácsik-Valent, Bernadett

AU - Lukácsi, Szilvia

AU - Kiss, Richárd

AU - Török, Katalin

AU - Kremlitzka, Mariann

AU - Bajtay, Z.

AU - Demeter, J.

AU - Bödör, Csaba

AU - Erdei, A.

PY - 2017/9/1

Y1 - 2017/9/1

N2 - The expression and role of CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in B cells are not yet explored in contrast to myeloid cells, where these β2-integrin type receptors are known to participate in various cellular functions, including phagocytosis, adherence and migration. Here we aimed to reveal the expression and role of CR3 and CR4 in human B cells. In B cells of healthy donors CR3 and CR4 are scarcely expressed. However, two patients with chronic lymphocytic leukemia (CLL) characterized by a peculiar immune-phenotype containing both CD5-positive and CD5-negative B cell populations made possible to study these molecules in distinct B cell subsets. We found that CD11b and CD11c were expressed on both CD5-positive and CD5-negative B cells, albeit to different extents. Our data suggest that these receptors are involved in spreading, since this activity of CpG-activated B cells on fibrinogen could be partially blocked by monoclonal antibodies specific for CD11b or CD11c. CpG-stimulation lead to proliferation of both CD5-positive and CD5-negative B cells of the patients with a less pronounced effect on the CD5-positive cells. In contrast to normal B cells, CLL B cells of both patients reacted to CpG-stimulation with robust IL-10 production. The concomitant, suboptimal stimulus via the BCR and TLR9 exerted either a synergistic enhancing effect or resulted in inhibition of proliferation and IL-10 production of patients’ B cells. Our data obtained studying B cells of leukemic patients point to the role of CR3 and probably CR4 in the interaction of tumor cells with the microenvironment and suggest the involvement of IL-10 producing B cells in the pathologic process.

AB - The expression and role of CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in B cells are not yet explored in contrast to myeloid cells, where these β2-integrin type receptors are known to participate in various cellular functions, including phagocytosis, adherence and migration. Here we aimed to reveal the expression and role of CR3 and CR4 in human B cells. In B cells of healthy donors CR3 and CR4 are scarcely expressed. However, two patients with chronic lymphocytic leukemia (CLL) characterized by a peculiar immune-phenotype containing both CD5-positive and CD5-negative B cell populations made possible to study these molecules in distinct B cell subsets. We found that CD11b and CD11c were expressed on both CD5-positive and CD5-negative B cells, albeit to different extents. Our data suggest that these receptors are involved in spreading, since this activity of CpG-activated B cells on fibrinogen could be partially blocked by monoclonal antibodies specific for CD11b or CD11c. CpG-stimulation lead to proliferation of both CD5-positive and CD5-negative B cells of the patients with a less pronounced effect on the CD5-positive cells. In contrast to normal B cells, CLL B cells of both patients reacted to CpG-stimulation with robust IL-10 production. The concomitant, suboptimal stimulus via the BCR and TLR9 exerted either a synergistic enhancing effect or resulted in inhibition of proliferation and IL-10 production of patients’ B cells. Our data obtained studying B cells of leukemic patients point to the role of CR3 and probably CR4 in the interaction of tumor cells with the microenvironment and suggest the involvement of IL-10 producing B cells in the pathologic process.

KW - Adhesion and spreading

KW - CLL B cells

KW - Expression of CR3 and CR4

KW - IL-10 production

UR - http://www.scopus.com/inward/record.url?scp=85020181631&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020181631&partnerID=8YFLogxK

U2 - 10.1016/j.imlet.2017.05.016

DO - 10.1016/j.imlet.2017.05.016

M3 - Article

VL - 189

SP - 73

EP - 81

JO - Immunology Letters

JF - Immunology Letters

SN - 0165-2478

ER -